Cassava Sciences Inc (FRA:PX91)
€ 2.194 -0.115 (-4.98%) Market Cap: 111.17 Mil Enterprise Value: -4.98 Mil PE Ratio: 0 PB Ratio: 0.69 GF Score: 39/100

Cassava Sciences Inc at H C Wainwright Global Investment Conference (Virtual) Transcript

Sep 13, 2022 / 07:30PM GMT
Release Date Price: €31.2 (-6.12%)
Unidentified Participant;Remi Barbier
Cassava

Hello, everyone, and thank you for joining the H.C. Wainwright 24th annual global investment hybrid conference from September 12-14, 2022. My name is [Jade]. And I'm a Biotech Equity Research Associate here at H.C. Wainwright.

While we are hybrid this year, we're confident that we are going to be able to provide value to you with over 650 companies presenting at this conference across multiple sectors. The in-person venue for the event is the Lotte New York Palace Hotel in New York City. Virtual participation will be stated simultaneously with over 550 company presentation schedule as live feed and available on-demand.

Please join us for one-on-one meetings, corporate presentations, and panels that will be live and streaming from September 12-14. With that said, have a productive and enjoyable day.

And I'd like to introduce our presenter. I'd like to welcome, Remi Barbier who's the President and CEO of Cassava Sciences, a clinical-stage biopharmaceutical company focused on neuroscience. Over to you, Remi.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot